Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
1426 |
|
| Actual shortage: | 205 (14%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 1220 (86%) | |
Discontinuation Reports |
231 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 228 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
235 (14%) |
|
Overdue reports |
6 (3%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
| ACT AMPHETAMINE XR | 5MG 5MG 5MG 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60075 |
| ACT AMPHETAMINE XR | 2.5MG 2.5MG 2.5MG 2.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-30 | 2019-01-31 | 68265 |
| ACT AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60068 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2017-04-03 | 2019-01-03 | 5192 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2017-04-03 | 2019-01-03 | 5189 |
| ACT AMPHETAMINE XR | 1.25MG 1.25MG 1.25MG 1.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61336 |
| ACT AMPHETAMINE XR | 6.25MG 6.25MG 6.25MG 6.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61330 |
| ACT AMPHETAMINE XR | 7.5MG 7.5MG 7.5MG 7.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61333 |
| RATIO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2017-03-14 | 2018-12-21 | 2343 |
| RATIO-AMCINONIDE | 0.1% | OINTMENT | Actual shortage | 2017-08-01 | 2018-12-21 | 17796 |
| RATIO-AMCINONIDE | 0.1% | CREAM | Actual shortage | 2017-08-01 | 2018-12-21 | 17799 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Actual shortage | 2017-08-01 | 2018-12-21 | 17856 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Actual shortage | 2017-08-01 | 2018-12-21 | 17893 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Actual shortage | 2017-08-02 | 2018-12-21 | 17976 |
| TEVA-PROPRANOLOL | 20MG | TABLET | Actual shortage | 2017-08-02 | 2018-12-21 | 17979 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 2800UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23143 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 5600UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23146 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-03-13 | 2018-12-07 | 42562 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |